Resectin

Composition

Resectin tablet: Each film coated tablet contains Ranitidine Hydrochloride USP 168 mg equivalent to Ranitidine 150 mg.

Description

Resectin tablet contains a medicine called Ranitidine. This belongs to a group of medicines called H2-receptor antagonists. It lowers the amount of acid in stomach.

Indication

  • Benign gastric and duodenal ulcer
  • NSAID associated duodenal or gastric ulcer
  • Zollinger-Ellison syndrome
  • Gastro-esophageal reflux disease
  • Acid-related dyspepsia

Dosage and Administration Adults:

Benign gastric and duodenal ulcer: 150 mg twice daily for 4 weeks Gastro-esophageal reflux disease: 150 mg twice daily for up to 8 weeks Zollinger-Ellison syndrome: 150 mg 3 times daily.

Children:

The recommended oral dose for the treatment of peptic ulcer in children is 2 mg/kg to 4 mg/kg twice daily to a maximum of 300 mg.

Use in special group

Pregnancy and lactation: Ranitidine should be used considering the risk benefit ratio.

Side effect

Headache, flatulence, nausea, abdominal pain, diarrhea, dry mouth, dizziness/vertigo and constipation.

Contraindication

Patients with known hypersensitivity to any component of the formulation.

Precaution

Caution should be taken in patients with renal impairment, pregnancy & lactation.

Storage

Keep out of the reach of children. Keep below 30°C, protect from light.

How Supplied

Resectin tablet: Each box contains 10 x 10’s tablet in blister pack.